Table 1.
The Relationship Between COLEC12 Expression and the Clinicopathological Features of Gastric Cancer Patients.a
| Characteristic | Low expression of COLEC12 | High expression of COLEC12 | P value |
|---|---|---|---|
| N | 187 | 188 | |
| Age, n (%) | .880 | ||
| <65 | 83 (22.4%) | 81 (21.8%) | |
| >65 | 102 (27.5%) | 105 (28.3%) | |
| Gender, n (%) | .251 | ||
| Female | 61 (16.3%) | 73 (19.5%) | |
| Male | 126 (33.6%) | 115 (30.7%) | |
| Histological type, n (%) | <.001 | ||
| Diffuse type | 21 (5.6%) | 42 (11.2%) | |
| Mucinous type | 5 (1.3%) | 14 (3.7%) | |
| Not otherwise specified | 103 (27.5%) | 104 (27.8%) | |
| Papillary type | 4 (1.1%) | 1 (0.3%) | |
| Signet ring type | 6 (1.6%) | 5 (1.3%) | |
| Tubular type | 48 (12.8%) | 21 (5.6%) | |
| T stage, n (%) | .016 | ||
| T1 | 15 (4.1%) | 4 (1.1%) | |
| T2 | 47 (12.8%) | 33 (9%) | |
| T3 | 81 (22.1%) | 87 (23.7%) | |
| T4 | 44 (12%) | 56 (15.3%) | |
| N stage, n (%) | .326 | ||
| N0 | 63 (17.6%) | 48 (13.4%) | |
| N1 | 47 (13.2%) | 50 (14%) | |
| N2 | 38 (10.6%) | 37 (10.4%) | |
| N3 | 32 (9%) | 42 (11.8%) | |
| M stage, n (%) | .965 | ||
| M0 | 167 (47%) | 163 (45.9%) | |
| M1 | 12 (3.4%) | 13 (3.7%) | |
| Pathologic stage, n (%) | .010 | ||
| Stage I | 38 (10.8%) | 15 (4.3%) | |
| Stage II | 51 (14.5%) | 60 (17%) | |
| Stage III | 70 (19.9%) | 80 (22.7%) | |
| Stage IV | 19 (5.4%) | 19 (5.4%) | |
| Histologic grade, n (%) | <.001 | ||
| G1 | 4 (1.1%) | 6 (1.6%) | |
| G2 | 90 (24.6%) | 47 (12.8%) | |
| G3 | 88 (24%) | 131 (35.8%) |
Abbreviation: COLEC12, Collectin subfamily member 12.
a
Numbers in bold are statistically significant (P < .05).